German reforms: The Third Stage

19 December 1994

The third stage of the German health service reform must ensure that the stability of health insurance premiums is legally guaranteed, Health Minister Horst Seehofer has said in Bonn. he added that the public-sector health funds must remain "oriented towards quality."

However the minister, who has still to discuss details of the third-stage reform with health care organizations and professionals as well as the coalition political parties, made no mention of any other aspects of policy. This is partly because in forthcoming talks with doctors, hospitals and health funds, Mr Seehofer is seeking to find out what they demand of the health service. A final policy statement will be published in June 1995.

Current budgets which limit health fund spending expire at the end of 1995, but the minister is understood to believe that if agreement can be reached over the future shape of the service, those running it can be relied on not to trigger a new explosion in health spending.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight